Cargando…

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Ren, Zhigang, Ma, Xiaochao, Duan, Zhenfeng, Chen, Xinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023837/ https://www.ncbi.nlm.nih.gov/pubmed/32089989 http://dx.doi.org/10.1155/2020/8157406

Ejemplares similares

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients
por: Zhu, Weiwei, et al.
Publicado: (2018)

Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis
por: Jiang, Han-Yu, et al.
Publicado: (2018)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Whither α-FP in the diagnosis of hepatocellular carcinoma?
por: Kew, Michael C
Publicado: (2015)

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013)

Precision oncology and molecular therapies for hepatocellular carcinoma
por: Chen, Liming, et al.
Publicado: (2022)

Long-term prognosis and management of hepatocellular carcinoma after curative treatment
por: Nishida, Naoshi
Publicado: (2020)

Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013)

Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
por: Piñero, Federico, et al.
Publicado: (2018)

Hepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies
por: Guan, Yong-Song, et al.
Publicado: (2014)

Development of conversion therapy for advanced hepatocellular carcinoma
por: Matsuki, Ryota, et al.
Publicado: (2023)

Current Approach and Future Directions in the Diagnosis and Prognosis of Keratinocyte Carcinomas
por: Scheau, Cristian, et al.
Publicado: (2023)

Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma
por: Cristea, CG, et al.
Publicado: (2015)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients
por: Gao, Ruize
Publicado: (2022)

Retinitis Pigmentosa: Disease Mechanisms, Diagnosis, and Therapies
por: Shu, Xinhua, et al.
Publicado: (2015)

Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma
por: Dai, Meiyu, et al.
Publicado: (2017)

Ethanolamine-phosphate phospho-lyase (ETNPPL) contributes to the diagnosis, prognosis, and therapy of hepatocellular carcinoma
por: Zhang, Yun, et al.
Publicado: (2023)

Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials
por: Hsueh, Chung-Tsen, et al.
Publicado: (2013)

Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update
por: Kudo, Masatoshi
Publicado: (2023)

Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
por: Lee, Sung Won, et al.
Publicado: (2023)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2022)

Caspase polymorphisms and prognosis of hepatocellular carcinoma
por: Zhang, Song, et al.
Publicado: (2017)

Preclinical Study of Locoregional Therapy of Hepatocellular Carcinoma by Bioelectric Ablation with Microsecond Pulsed Electric Fields (μsPEFs)
por: Chen, Xinhua, et al.
Publicado: (2015)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
por: Kim, So Yeon
Publicado: (2020)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
por: Piñero, Federico, et al.
Publicado: (2020)

Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma
por: Liu, Meijin, et al.
Publicado: (2023)

Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
por: Khare, Tripti, et al.
Publicado: (2017)

Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
por: Hayashi, Tsuguru, et al.
Publicado: (2020)

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success
por: Da Fonseca, Leonardo G., et al.
Publicado: (2018)

Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
por: Yoon, Sang Min
Publicado: (2023)

Possible Therapies for Hepatocellular Carcinoma—Preparing for the Modern War with the Insidious Enemy
por: Wasilewicz, Michał P.
Publicado: (2023)

Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Zhi-kun, et al.
Publicado: (2017)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rh8o8i4943krfroo872osdoe6t